https://hstalks.com/category/764/cancer/?biosci New and updated series & talks on Cancer from HSTalks' Biomedical & Life Sciences Collection. daily 1 2006-01-01T12:00+00:00 Henry Stewart Talks en © Copyright Henry Stewart Talks Ltd. The Biomedical & Life Sciences Collection © Copyright Henry Stewart Talks Ltd. https://hstalks.com/t/23422/neoantigen-vaccines-in-cancer-immunotherapy-a-brea/?biosci Renal cell carcinoma - Personalized neoantigen vaccines - Cancer immunotherapy - Neoantigen targeting - T-cell immune responses - Immune checkpoint inhibitors - Adjuvant therapy - Clinical trials Neoantigen vaccines in cancer immunotherapy: a breakthrough in renal cell carcinoma Dr. David A. Braun Renal cell carcinoma, Personalized neoantigen vaccines, Cancer immunotherapy, Neoantigen targeting, T-cell immune responses, Immune checkpoint inhibitors, Adjuvant therapy, Clinical trials 2026-07-30 2026-07-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/22960/immunotherapy-in-cancer-research-recent-advancemen/?biosci Cancer immunotherapy - Immune checkpoint blockade - Personalized cancer vaccines - CAR-T & TCR cell therapy - Bispecific T-cell engagers - Biomarker discovery - AI & multi-omics in oncology - Glioblastoma and tumor microenvironment Immunotherapy in cancer research: recent advancements (2026) Prof. Mustafa Khasraw Cancer immunotherapy, Immune checkpoint blockade, Personalized cancer vaccines, CAR-T & TCR cell therapy, Bispecific T-cell engagers, Biomarker discovery, AI & multi-omics in oncology, Glioblastoma and tumor microenvironment 2026-07-30 2026-07-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/21838/current-emerging-therapies-for-the-management-of-p/?biosci Endometrial cancer - Classification of endometrial cancer - Single agent immunotherapy in biomarker selected endometrial cancers - First-line treatment of advanced or recurrent endometrial cancer - Adding PARP inhibition to first line - Adjuvant therapy - Antibody drug conjugates in endometrial cancer - Cell cycle checkpoint inhibitors in endometrial cancers - Hormonal therapy - Biomarker based therapy Current & emerging therapies for the management of patients with endometrial cancer Prof. Brian Slomovitz Endometrial cancer, Classification of endometrial cancer, Single agent immunotherapy in biomarker selected endometrial cancers, First-line treatment of advanced or recurrent endometrial cancer, Adding PARP inhibition to first line, Adjuvant therapy, Antibody drug conjugates in endometrial cancer, Cell cycle checkpoint inhibitors in endometrial cancers, Hormonal therapy, Biomarker based therapy 2026-07-30 2026-07-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/24748/dna-repair-mechanisms/?biosci DNA damage sources and types - DNA repair pathways (BER, NER, MMR) - DNA polymerase and ligase roles - Repair defects in cancer and aging - DNA repair in disease prevention and treatment DNA repair mechanisms DNA damage sources and types, DNA repair pathways (BER, NER, MMR), DNA polymerase and ligase roles, Repair defects in cancer and aging, DNA repair in disease prevention and treatment 2026-07-30 2026-07-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/24751/antibody-drug-conjugates-adcs/?biosci Antibody-drug conjugate concept - ADC structure and components - Targeted cancer cell delivery - Clinical ADC applications - ADC benefits over standard cancer therapy - Challenges in ADC development - Future directions in personalized medicine Antibody-drug conjugates (ADCs) Antibody-drug conjugate concept, ADC structure and components, Targeted cancer cell delivery, Clinical ADC applications, ADC benefits over standard cancer therapy, Challenges in ADC development, Future directions in personalized medicine 2026-07-30 2026-07-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/4459/mode-of-action-of-t-cells-engineered-with-car-or-t/?biosci Genetically engineered T cells - T cell receptor modified T cells - Chimeric antigen receptor modified T cells - Anti-CD19 CAR T cell treatment - Tumor infiltrating lymphocytes Mode of action of T cells engineered with CAR or TCR for cancer treatment Prof. Dr. Sebastian Kobold Genetically engineered T cells, T cell receptor modified T cells, Chimeric antigen receptor modified T cells, Anti-CD19 CAR T cell treatment, Tumor infiltrating lymphocytes 2026-06-30 2026-06-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/19000/antiangiogenic-cancer-therapy/?biosci Anti-cancer drugs - Angiogenesis - Tumour growth and angiogenesis - Key signalling pathways for angiogenesis - Anti-VEGF drugs - Functions of VEGF and VEGF-VEGFR signaling - Antiangiogenic cancer therapy - Antiangiogenic drug resistance (AAD) - Impact of AAD on tumor and healthy vasculature - Antiangiogenic chemotherapeutics Antiangiogenic cancer therapy Prof. Yihai Cao Anti-cancer drugs, Angiogenesis, Tumour growth and angiogenesis, Key signalling pathways for angiogenesis, Anti-VEGF drugs, Functions of VEGF and VEGF-VEGFR signaling, Antiangiogenic cancer therapy, Antiangiogenic drug resistance (AAD), Impact of AAD on tumor and healthy vasculature, Antiangiogenic chemotherapeutics 2026-06-30 2026-06-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/17944/the-impact-of-diet-on-natural-killer-cell-metaboli/?biosci Dietary fasting and systemic metabolic changes - Natural killer cell metabolism under cyclic fasting diet (CFD) - Role of fatty acid oxidation in NK Cell anti-tumor function - Fasting promotes NK cell redistribution to and priming within the bone marrow - CFD-induced metabolic changes in NK cells enhance anti-tumor immunity The impact of diet on natural killer cell metabolism and anti-tumor function Dr. Rebecca Delconte Dietary fasting and systemic metabolic changes, Natural killer cell metabolism under cyclic fasting diet (CFD), Role of fatty acid oxidation in NK Cell anti-tumor function, Fasting promotes NK cell redistribution to and priming within the bone marrow, CFD-induced metabolic changes in NK cells enhance anti-tumor immunity 2026-05-28 2026-05-28 The Biomedical & Life Sciences Collection https://hstalks.com/t/21097/advancing-biological-discovery-through-proteomics-/?biosci AI in biology - Biomarkers - Drug discovery - Mass spectrometry - Protein identification - Proteomics - Precision medicine Advancing biological discovery through proteomics: from mass spectrometry to medicine Prof. John Yates AI in biology, Biomarkers, Drug discovery, Mass spectrometry, Protein identification, Proteomics, Precision medicine 2026-05-28 2026-05-28 The Biomedical & Life Sciences Collection